Evidence map›Paper›PMID 40483442›Full record

ArticleItalian journal of pediatrics2025

Subacute sclerosing panencephalitis as a re-emerging condition due to low vaccination coverage: a case-series.

Gabriella Errichiello, Francesco Tengattini, Silvia Gioacchini, Maria Fulvia De Leva, Stefania Graziano, Giorgia Bruno, Paola Bucci, Emilio D'Ugo, Claudio Ruggiero, Fabio Magurano and 1 more

Abstract readCase Reports
In one paragraph

Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gabriella Errichiello *Pediatric Neurology Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy. gabriellaerrichiello29@gmail.com.ORCID http://orcid.org/0009-0006-8980-1120
Francesco Tengattini *Neurosurgery Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
Silvia GioacchiniDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Maria Fulvia De LevaPediatric Neurology Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
Stefania GrazianoPediatric Neurology Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
Giorgia Bruno *Pediatric Neurology Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
Paola BucciDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Emilio D'UgoDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Claudio RuggieroNeurosurgery Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.
Fabio MaguranoDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Antonio VaronePediatric Neurology Unit, Department of Neurosciences, Santobono-Pausilipon Children's Hospital, Naples, Italy.

Funding

Fondazione Santobono Pausilipon 2300
6 · The paper itself

Abstract

backgroundSubacute sclerosing panencephalitis (SSPE) is a chronic progressive disease affecting the central nervous system (CNS) because of persistent measles virus (MeV) infection. The disease presents with a range of symptoms, starting with gradual cognitive and motor decline, progressing to coma, vegetative state, and typically resulting in death within 3-4 years of clinical onset. The incidence of SSPE is inversely related to vaccination coverage and its pathogenesis remains poorly understood. The primary risk factor is infection by the wild type of measles virus, particularly in individuals who may be predisposed to infection due to a lack of herd immunity or immunosuppressed states. Furthermore, the risk of developing SSPE increases with the younger age at which a person contracts measles. CASE PRESENTATION: We provide a description of the disease, characterizing its clinical course, diagnostic work-up and treatment options. We will also present a series of cases observed at the Santobono-Pausilipon Children's Hospital, in Naples, Italy, highlighting both typical and atypical presentations, with a particular emphasis on the pharmacological and neurosurgical treatments for the condition.

conclusionsThe objective of this study is to raise awareness about the increasing prevalence of conditions following the SARS-Cov2 pandemic, with an emphasis on the importance of vaccination adherence as the only effective prevention method for SSPE.

Indexed as

COVID-19Subacute Sclerosing PanencephalitisVaccination CoverageAdolescentChildChild, PreschoolFemaleHumansItalyMaleMeaslesInterferon alphaMeaslesSeizuresSSPEVaccine

Identifiers

PMID40483442
PMCPMC12145622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.